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Abstract
Nephrotic syndrome is a general type of kidney disease seen in children. In the 
past, Roelans is credited with the first clinical description of nephrotic syndrome 
in the late fifteenth century. Nephrotic syndrome is appropriate to excessive 
hypoalbuminemia, edema, and proteinuria may be hyperlipidemia also present 
in some cases. Periorbital swelling with or without edema of the body is observed 
in first starting little period of life, frequently show in children with this condi-
tion. Nephrotic syndrome starts develops due functional and structural changes 
in the GFB, consequential difficulty to control protein in the urine. Nephrotic 
syndrome possibly causes due to some of glomerular diseases and systemic 
diseases, but significantly the mostly in childhood is unknown nephrotic syn-
drome. The first significant improvement with introduction of sulfonamides and 
then penicillin was seen in 1939. The beginning of adrenocorticotropic hormone 
and cortisone greater decrease in mortality (to 9%), in the 1950s it was noted to 
happen in association with spectacular declaration of proteinuria. Etiology of 
nephrotic syndrome is also age reliant. Most cases reported in the first 3 months 
of life are referred to as congenital nephrotic syndrome (CNS) and are due to 
genetic diseases.
Keywords: nephrotic syndrome, hypoalbuminemia, proteinuria,  
glomerular filtration barrier, congenital nephrotic syndrome
1. Introduction
Nephrotic syndrome is a general type of kidney disease seen in children. 
Historically, Roelans is credited with the first clinical description of nephrotic 
syndrome in the late fifteenth century. Nephrotic syndrome is appropriate to 
excessive hypoalbuminemia, proteinuria, and edema, although additional clini-
cal hyperlipidemia is also usually present. The beginning of adrenocorticotropic 
hormone and cortisone in the 1950s contributed to an even greater decrease in 
mortality (to 9%), which was noted to occur in association with dramatic resolu-
tion of proteinuria.
Renal Diseases
2
2. Causes
The childhood nephrotic syndrome is principally idiopathic or primary, though 
a limited number of cases are secondary to glomerular and inclusive diseases and 
other infectious agents. Age reliant is also the etiology factor of nephrotic syn-
drome. Maximum cases presenting in the first 3 months of lifespan are mentioned 
as CNS (congenital nephrotic syndrome) and are caused by genetic diseases. While 
in the remaining of the first year of lifecycle (3–12 months) there has been no effec-
tive study of the etiology of nephrotic syndrome reported cases, there are a number 
of stats shows that up to 40% of reported cases meanwhile this time may also be 
due to genetic factors [1]. At the time of first year and in the first decade of life, 
maximum presenting cases are due to primary or idiopathic nephrotic syndrome, at 
the time of first 10 years of lifecycle the number of secondary nephrotic syndrome 
cases increases.
2.1 Inborn nephrotic syndrome
Congenital nephrotic syndrome is the type of nephrotic syndrome which occurs 
in first 3 months of life and is due to genetic causes mostly by alterations in the gene 
encrypting nephrin, a podocyte opening diaphragm protein. For the first time, 
these mutations were expressed in the Finnish, from then the name congenital 
nephrotic syndrome of the Finnish type (CNF) [1]. Though the incidence of CNF 
is high in Finland it also occurs in other populations also. Congenital nephrotic 
syndrome is not either equivalent with CNF, reason is that alterations in other genes 
encrypting podocyte opening diaphragm proteins, early-onset nephrotic syndrome 
can also be caused by proteins such as podocin. Upto 40% of all cases of nephrotic 
syndrome occurring in the first 3 months of life are due to alterations in a sequence 
of podocin gene [2] in the earliest 3 months of life. Nephrotic syndrome may also be 
part of multisystemic syndromes such as nail-patella syndrome, Pierson syndrome, 
Denys-Drash syndrome, and others or a sequence of congenital infections such as 
cytomegalovirus and syphilis (Table 1).
Genetic Mutation in nephrin (NPHS1) gene leads to congenital nephrotic syndrome of the 
Finnish type (CNF)
Mutation in podocin (NPHS2) gene results Autosomal recessive FSGS
Mutation in WT1 gene results Autosomal dominant diffuse mesangial Sclerosis (DMS)
Mutation in laminin β2 gene leads Congenital nephrotic syndrome
Syndromes Nail-patella syndrome due to mutation in LIM homeodomain protein (LMX1B)
Jeune’s syndrome
Galloway Mowat syndrome
Denys-Drash syndrome due to WT1 mutation with DMS
Pierson syndrome
Schimke immunoosseous dysplasia with FSGS due to mutation in SMARCAL1
Cockayne syndrome
Idiopathic Nonsyndromic DMS
Minimal change nephrotic syndrome
FSGS
Infections Congenital toxoplasmosis
Congenital cytomegalovirus (CMV) infection
Congenital syphilis
Table 1. 
Causative factors of congenital nephrotic syndrome (CNS) in 0–3 months of age.
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2.2 Nephrotic syndrome after infancy
Above the infancy and above the first year of life, maximum of the nephrotic syn-
drome cases are idiopathic. MCNS (Minimal-Change Nephrotic Syndrome) is the most 
usual deviation, and is responsible for more than 80% of all cases [3]. Focal segmental 
glomerulosclerosis (FSGS), Membranoproliferative glomerulonephritis (MPGN), and 
mesangial multiply glomerulonephritis are the other less common histopathologic 
types in this age group (Table 2). For a few cases in this age group genetic disease is 
also responsible. 10–25% of all cases of familial and sporadic SRNS were caused by 
Idiopathic C1q nephropathy
IgM nephropathy
Membranous nephropathy (MN)
Membranoproliferative glomerulonephritis (MPGN)
Minimal change nephrotic syndrome (MCNS)
Focal segmental glomerulosclerosis (FSGS)
Mesangial proliferative glomerulonephritis
Hereditary Mutation in WT1 gene results autosomal dominant diffuse mesangial Sclerosis 
(DMS)
Mutation in gene encoding transient receptor potential cation channel 6 (TRPC6) 
results Autosomal dominant FSGS
Mutation in gene encoding CD2-associated protein (CD2AP) results autosomal 
dominant FSGS
Mutation in gene encoding α-actinin 4 leads to autosomal dominant FSGS
Mutation in podocin(NPHS2) gene results autosomal recessive FSGS
Drugs NSAIDs
Penicillamine
ACEIs
Pamidronate
Gold
Lithium
Mercury
Interferon
Heroin
Metabolic diseases Glutaric acidemia
Mitochondrial cytopathies
Glycogen storage disease
Fabry’s disease
General diseases Systemic lupus erythematosus
Sarcoidosis
Diabetes mellitus
Henoch-Schönlein purpura
Blood and oncologic 
diseases
Lymphoma (Hodgkin’s most likely can lead to minimal change)
Leukemia
Sickle cell disease
Infections HIV
Malaria
Filariasis
Schistosomiasis
Hepatitis B and C
Others Food allergies
Obesity (usually with FSGS)
Bee stings (MCNS)
Pregnancy
Oligomeganephronia
Table 2. 
Causative factors of nephrotic syndrome above 3 months of life.
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mutations in NPHS2, inherited in an autosomal genetic mode, because it was exposed 
in one series. Beginning of nephrotic syndrome in untimely childhood, not response 
to steroid treatment, strong findings of focal segmental glomerulosclerosis (FSGS) on 
histopathology renal biopsy, progress to ESRD in 5 years of finding, and comprehen-
sively decreases the risk of disease recurrence following renal transplantation are by 
the phenotype typically associated with NPHS2 mutations [4, 5]. Additional genetic 
factors consists autosomal dominant transmitted causes such as α-actinin 4, mutations 
in the Wilms’ tumor suppressor gene (WT1), TRPC6 and CD2AP [6–10]. Individually 
from those in WT1, maximum of these mutations go to result in adult-onset disease. To 
a number of systemic diseases in children, nephrotic syndrome may also be secondary. 
Pediatric diseases such as Henoch-Schönlein purpura; diabetes mellitus; systemic lupus 
erythematosus, especially membranous (WHO Class V) SLE; and sarcoidosis may all 
exist with nephrotic syndrome. Infective factors can also cause nephrotic syndrome 
and can be bacterial, viral, or parasitic. Despite it is not so far fully known how these 
factors cause nephrotic syndrome, it is maybe due to an bizarre immune response to 
them in the majority of the reported cases, occurring in the progression and aggrega-
tion of immune complexes in the glomerulus. The interpretation of these factors as a 
cause of nephrotic syndrome turn to parallel their prevalence in demanding regions of 
the world. For example, in Hong Kong and countries in Africa, hepatitis B and C are 
important causes of nephrotic syndrome [11, 12]. In areas where malaria is endemic, 
Malaria, particularly quartan malaria, is also an important cause. Eighteen nephrotic 
syndrome in both adults and children can be caused by Human immunodeficiency 
virus (HIV).despite the renal abrasion linked with HIV can be changeable, FSGS is the 
most common histologic finding affiliated with HIV is, particularly the breakdown is 
different. Despite the result of treatment of the underlying infection on the nephropa-
thy is not well known, but there are details that hepatitis B-associated nephrotic syn-
drome may be cooperative to treatment of the hepatitis [13]. A list of infective factors 
associated with nephrotic syndrome is shown in Table 2. Drugs such as angiotensin 
converting enzyme inhibitors (ACEIs), penicillamine, gold, nonsteroidal antiinflam-
matory drugs (NSAIDs), sickle cell disease, bee stings, lymphoma, leukemia, and vari-
ous types of food allergies are the other less common causes of nephrotic syndrome. 
Moreover, in children with obesity the nephrotic syndrome is being seen further 
recurrently. The histologic scrape most frequently occurs in this setting is FSGS.
3. Mechanism of nephrotic syndrome
The development of massive proteinuria is the central abnormality in all cases 
of nephrotic syndrome. Some of the literature shows the evidence in that nephrotic 
syndrome may be a significance of glomerular defect, circulating factors, and defect 
in immunological system.
3.1 Glomerular defect
The most important possible functions of the kidney is the filtration of blood 
and blood products at glomeruli, which permits the fluid and dirty products while 
retaining the greater part of blood proteins and all blood cells within the vasculature. 
These types of process of filtration is made potential by the (GFB), which is made up 
of specific glomerular epithelial cells (podocytes), endothelial cells, and GBM these 
distal bottom actions are attached to the GBM (Figure 1) [14]. Adjacent podocyte 
bottom actions are associated to each one other by networks of specific cell-cell 
junctions called as opening diaphragms. Additionally, the GBM (glomerular basement 
membrane) has a plentiful supplies of negatively charged molecules of heparin sulfate 
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proteoglycan, resultant in these negatively charged heparin sulfate proteoglycan 
controlled from passage than positively charged molecules with same particles [15]. 
General healthy system, particle more than 42 Å in diameter is not capable to enter 
into the GFB [16]. This kind of restrictions based on mostly structural reliability of 
the podocyte bottom actions and opening diaphragms, by means of the charge of 
GBM. Loss of negative charge of the GBM occurs in nephrotic syndrome [17–19]. The 
confirmation, swelling and diffusion podocyte binds to bottom actions, dislocation of 
opening diaphragms, occurrence of filling junctions, vacuole formation, and defi-
ciency of inclusion of podocytes from the GBM, these type of morphologic changes 
in podocytes that occur during progress of nephrotic syndrome [20–23]. Mutations in 
genes encoding some of the opening diaphragms proteins or their transcription factors 
can cause SRNS and/or FSGS. This mechanism of nephrotic syndrome is additional 
reinforced by recent observations in humans and experimental animals [4, 10, 11, 
14, 24–26]. The subject of many recent reviews in the literature this type of result 
have been discussed [27–29]. In infants mutations in the gene encoding the opening 
diaphragms protein nephrin (NPHS1) mostly causes CNF. In addition, in children 
mutations in NPHS2 are estimated to be responsible for up to 25% of cases of sporadic 
familial and Steroid resistant nephrotic syndrome (SRNS) [10, 25]. Frasier syndrome 
and Denys rash syndrome in children occurs due to Mutations in the transcription fac-
tor suppressor gene WT1 [30–32]. Mutations in (1) CD2-associated protein (CD2AP); 
(2) the LIM-homeodomain protein (encoded by LMX1B), which leads to in nail-patella 
syndrome; (3) the actin-bundling protein α-actinin 4, which leads to adult-onset 
FSGS; which results in adult-onset FSGS; (4) laminin β2, which results in Pierson 
syndrome and (5) the chromatin regulator encoded by SMARCAL1. [25, 33–35].
3.2 Circulatory factors
Some of soluble mediators that may alter capillary wall permeability in nephrotic 
syndrome proved by investigational data to carry the existence [37–39] show to be 
true for this includes (1) scared decrease of proteinuria subsequent treatment with 
protein A immunoadsorption in of primary nephrotic syndromes [24], (2) progress 
of nephrotic syndrome in child babies born to mothers with nephrotic syndrome 
Figure 1. 
Components of the glomerular filtration barrier (GFB) during normal glomerular filtration, electron 
micrographic view.
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who actually transferred a soluble factor to their fetuses in utero [39], (3) decrease 
of repeated disease induced by treatment with protein A immunoadsorption due to 
presumed removal of circulating factors in the reappearance of FSGS in transplanted 
kidneys in patients with primary FSGS [40], and (4) FSGS recurrence in transplanted 
kidney patients serum injected in to the experimental animals leads to causing of 
enhanced glomerular permeability [32] serum of children with FSGS and recognized 
as components of apolipoproteins, from the suggestive of that an imbalance involving 
serum permeability factors and permeability inhibitors may have a pathogenic role in 
FSGS. Moreover, inhibitors of glomerular permeability have also been isolated [33].
3.3 Defect in immunological system
For more than 30 years nephrotic syndrome may be because of abnormalities of 
the immune system has existed. Both the humoral and cellular immune responses 
are abnormal during relapse of nephrotic syndrome. Still, have a thought that 
relationship between the nephrotic syndrome and T lymphocyte function was first 
proposed by Shalhoub and his colleagues and concluded that abnormalities in cel-
lular immune responses [36] proves for this includes (1) sensitivity of most forms of 
primary nephrotic syndrome to mycophenolate mofetil, corticosteroids, calcineurin 
inhibitors, and alkylating agents, these drugs all are inhibitors of T lymphocyte pur-
pose, (2) mostly measles and malaria, diseases well-known to slow down the cell-
mediated immunity following remission of nephrotic syndrome, and (3) detection 
of Minimal-Change Nephrotic Syndrome (MCNS) as a paraneoplastic manifestation 
of lymphoreticular malignancies and other Hodgkin’s disease. Latest reported cases 
have also suggested and vital role of the cell-mediated immune system in nephrotic 
syndrome, collectively with depressed cell-mediated immunity during relapses of 
MCNS alterations in T cell subsets during relapses and increased cell surface expres-
sion of IL-2 receptors on T cells, reflective of T cell activation [34, 41]. Additionally, 
a number of cytokines, released in part by T lymphocytes, have been recommended 
to be erratically changed throughout nephrotic syndrome (NS) [42, 43].
4. Pathophysiology
In children with nephrotic syndrome facial or general edema, is the basic symptom 
due to accumulation of fluid in the interstitial compartment. In nephrotic syndrome 
the edema is usually causes disproportionate proteinuria, which leads to retention of 
sodium and water, hypoalbuminemia to recompense for intravascular volume deple-
tion. The pathogenesis of edema can be well explained by analysis of the classic Starling 
equation, which explains the regulation of fluid movement across capillary walls [44].
Net filtration = LpS (Δ hydraulic pressure − Δ oncotic pressure).
  = LpS [(Pcap − Pif) − s(πcap − πif)].
where:
Lp = the capillary permeability.
S = the surface area of the capillary wall.
Pcap = the capillary hydrostatic pressure.
Pif = the interstitial fluid hydrostatic fluid pressure.
s = the reflection coefficient for proteins (0 = complete permeability and 
1 = complete impermeability).
πcap = the capillary oncotic pressure.
πif = the interstitial fluid oncotic pressure.
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The formation of edema is prevented in healthy patients by a balance between 
forces favoring edema (capillary hydrostatic pressure [Pcap]) and those opposing it 
(capillary oncotic pressure [πcap]). The slight tendency toward fluid accumulation 
is counterbalanced by the lymphatics in the interstitial space. In nephrotic patients 
hypoalbuminemia results when the liver fails to synthesize the loss of albumin 
through urine. The hypoalbuminemia results leads to low down capillary oncotic 
pressure (πcap), which leads to relatively unopposed capillary hydrostatic pressure 
(Pcap) and subsequent edema formation. Relative intravascular volume reduction 
is due to edema formation the intravascular volume which triggers neurohumoral 
compensatory mechanisms. Which includes sympathetic nervous system (SNS), argi-
nine vasopressin (AVP), and the renin angiotensin aldosterone system (RAAS), with 
Figure 2. 
Under fill hypothesis proposes the continuation of a reduced effective circulating blood volume in nephrotic 
syndrome. Pathophysiologic events leading to the formation of edema in nephrotic syndrome.
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the net causes being sodium and water retention by the kidney. In the background 
of nephrotic syndrome, aortic arch, left ventricle, mechanoreceptors in the carotid 
sinus, and afferent arterioles in the glomeruli detect reduced pressure distension. This 
produce (1) SNS outflow increases from the central nervous system, (2) RAAS activa-
tion, and (3) nonosmotic release of AVP from the hypothalamus. These three changes 
lead to peripheral vasoconstriction (increased SNS and angiotensin II), sodium reten-
tion (angiotensin II, aldosterone, and increased SNS), and water retention.
As a result of these mechanisms, it is greatly accepted that patients with nephrotic 
syndrome have an excess of total body water and sodium. The condition of their 
intravascular volume is to some amount controvertible. Intravascular state in nephrotic 
is demonstrated by the following hypothesis: so-called overfill hypothesis and under-
fill hypothesis. The continuation of a reduced effective circulating blood volume in 
nephrotic syndrome is explained by underfill hypothesis (Figure 2). Due to activation 
of the RAAS with resultant of reduction in urinary sodium excretion and elevation of 
aldosterone levels, is most expectedly promoted by findings of low urine sodium in the 
presence of edema. The low urinary sodium [45] is due to reduction of atrial natriuretic 
peptide (ANP). Evidence, additionally for the underfill hypothesis includes betterment 
in sodium excretion with albumin infusion or head-out water immersion, and reduced 
cardiac output and increased vascular evaluated. It is possible that the overfilled state 
may be major in the chronic phase during which patients may have long-lasting sodium 
retention due to unrelenting low-grade hypoalbuminemia. But the underfilled state 
may be major in the acute setting in which excessive proteinuria causes rapid develop-
ment of hypoalbuminemia and a gradual drop in plasma oncotic pressure.
Supposed to be intravascularly volume-expanded as different to degree- 
constricted, founding whether a child is underfilled versus overfilled can be 
clinically important in the edema in children with nephrotic syndrome may be 
different. Depends upon the below urinary estimations comparison with elevated 
plasma vasopressin, renin, norepinephrine, aldosterone levels they are Single group 
has support to estimate the relative urinary potassium excretion [UK/(UK + UNa 
and)] absolute excretion of sodium (FENa) to elucidate the distinction. Nephrotic 
patients who are with high urinary potassium excretion (>60%) and a low FENa 
(<1%) would be probable to have a low intravascular load [46].
5. Conclusion
Causes of nephrotic syndrome are also age reliant. The majority of the cases 
reported in the first 3 months of life is referred to as congenital nephrotic syndrome 
(CNS) and are because of genetic diseases. While there has been no efficient study 
of the etiology of nephrotic syndrome presenting in the rest of the first year of life 
(3–12 months), there are data telling that up to 40% of cases during this time may also 
be due to genetic causes. While it is extensively accepted that patients with nephrotic 
syndrome have an excess of total body sodium and water as a result of these remuner-
ative mechanisms, the status of their intravascular volume is to some extent contro-
versial. Nephrotic syndrome was a variety of disease processes with heavy proteinuria 
and hypoalbuminemia at its main symptoms. Although ongoing research hard work 
in the mechanism of disease, first-line therapy has stay over relatively unaffected 
for decades, and corticosteroids drugs are the basis of treatment Most children have 
MCNS, which come through a good prognosis; renal failure is uncommon in patients 
with MCNS. The manner of patients with nephrotic syndrome is changeable, but 
most patients will have periods of relapse and remission. Guidelines published by 
the American Academy of Pediatrics and the KDIGO can guide the pediatrician in 
the treatment of MCNS. There are alternative to corticosteroid therapy that has had 
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success in induction and/or maintenance of reduction, although findings are conflict-
ing, necessitating additional multicenter trials to contrast these medications head to 
head. Hypotheses concerning the mechanisms of proteinuria and the possible associa-
tion of glomerular structure to the nephrotic syndrome are discussed (Figure 3).
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Figure 3. 
Pathophysiologic events leading to the formation of edema in nephrotic syndrome according to the overfill 
hypothesis.
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Abbreviations
NS nephrotic syndrome
CNS congenital nephrotic syndrome
CNF congenital nephrotic syndrome of the Finnish type
ESRD end-stage renal disease
GBM glomerular basement membrane
SRNS steroid-resistant nephrotic syndrome
MPGN membranoproliferative glomerulonephritis
FSGS focal segmental glomerulosclerosis
MCNS minimal-change nephrotic syndrome
RAAS renin angiotensin aldosterone system
SNS sympathetic nervous system
AVP arginine vasopressin
GFB glomerular filtration barrier
SRNS steroid resistant nephrotic syndrome
Author details
Nagaraju Vallepu1*, Saikiran Velpula1, Bharath Kumar Dasari1,  
Manish Kumar Thimmaraju2, Sridhar Babu Gummadi3, Neeraja Yelugam1  
and Supraja Jannu1
1 Department of Pharmacy Practice, Balaji Institute of Pharmaceutical Sciences, 
Warangal, Telangana, India
2 Department of Pharmaceutical Analysis, Balaji Institute of Pharmaceutical 
Sciences, Warangal, Telangana, India
3 Sri Shivani College of Pharmacy, Warangal, Telangana, India
*Address all correspondence to: vallepunagaraju99@gmail.com
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
11
Causes and Pathophysiology of Nephrotic Syndrome in Childhood
DOI: http://dx.doi.org/10.5772/intechopen.86825
References
[1] Cattran DC, Feehally J, Cook HT, 
Liu ZH, Fervenza FC, Mezzano SA, 
et al. Kidney disease: Improving global 
outcomes (KDIGO) glomerulonephritis 
work group. KDIGO clinical practice 
guideline for glomerulonephritis. 
Kidney International Supplements. 
2012;2:139-274. DOI: 10.1038/
kisup.2012.9
[2] Arneil GC. The nephrotic syndrome. 
Pediatric Clinics of North America. 
1971;18(2):547-559
[3] Arneil GC, Lam CN. Long-term 
assessment of steroid therapy 
in childhood nephrosis. Lancet. 
1966;2(7468):819-821
[4] Lenkkeri U et al. Structure of 
the gene for congenital nephritic 
syndrome of the Finnish type (NPHS1) 
and characterization of mutations. 
American Journal of Human Genetics. 
1999;64(1):51-61
[5] Hinkes B et al. Genetic causes of 
nephrotic syndrome in the first year of 
life. American Pediatric Nephrology 
Meeting. Marburg; 2006
[6] Eddy AA, Symons JM. Nephrotic 
syndrome in childhood. Lancet. 
2003;362(9384):629-639
[7] Gipson DS, Troost JP, 
Lafayette RA, et al. Complete remission 
in the nephrotic syndrome study 
network. Clinical Journal of the 
American Society of Nephrology. 
2016;11:81-89
[8] Ruf RG et al. Patients with mutations 
in NPHS2 (podocin) do not respond 
to standard steroid treatment of 
nephrotic syndrome. Journal of the 
American Society of Nephrology. 
2004;15(3):722-732
[9] Weber S et al. NPHS2 mutation 
analysis shows genetic heterogeneity 
of steroid-resistant nephrotic 
syndrome and low post-transplant 
recurrence. Kidney International. 
2004;66(2):571-579
[10] Nash MA et al. The nephrotic 
syndrome. In: Edelmann CMJ, editor. 
Pediatric Kidney Disease. Boston: Little, 
Brown, and Company; 1992
[11] Srivastava T, Simon SD, Alon US. 
High incidence of focal segmental 
glomerulosclerosis in nephrotic 
syndrome of childhood. Pediatric 
Nephrology. 1999;13(1):13-18
[12] Ravani P, Rossi R, Bonanni A, et al. 
Rituximab in children with steroid-
dependent nephrotic syndrome: A 
multicenter, open-label, noninferiority, 
randomized controlled trial. Journal of 
the American Society of Nephrology. 
2015;26:2259-2266
[13] Coulthard MG. Oedema 
in kwashiorkor is caused by 
hypoalbuminaemia. Paediatrics 
and International Child Health. 
2015;35:83-89
[14] Hogg RJ et al. Evaluation and 
management of proteinuria and 
nephrotic syndrome in children: 
Recommendations from a pediatric 
nephrology panel established at 
the National Kidney Foundation 
conference on proteinuria, albuminuria, 
risk, assessment, detection, and 
elimination (PARADE). Pediatrics. 
2000;105(6):1242-1249
[15] McEnery PT, Strife CF. Nephrotic 
syndrome in childhood. Management 
and treatment in patients with minimal 
change disease, mesangial proliferation, 
or focal glomerulosclerosis. 
Pediatric Clinics of North America. 
1982;29(4):875-894
[16] Bonilla-Felix M et al. Changing 
patterns in the histopathology of 
Renal Diseases
12
idiopathic nephrotic syndrome in 
children. Kidney International. 
1999;55(5):1885-1890
[17] Wong SN, Yu EC, Chan KW.  
Hepatitis B virus associated 
membranous glomerulonephritis 
in children—Experience in Hong 
Kong. Clinical Nephrology. 
1993;40(3):142-147
[18] Bhimma R et al. Treatment 
of hepatitis B virus-associated 
nephropathy in black children. Pediatric 
Nephrology. 2002;17(6):393-399
[19] Filler G et al. Is there really an 
increase in non-minimal change 
nephrotic syndrome in children? 
American Journal of Kidney Diseases. 
2003;42(6):1107-1113
[20] Smoyer WE, Mundel P. Regulation 
of podocyte structure during the 
development of nephrotic syndrome. 
Journal of Molecular Medicine. 
1998;76(3-4):172-183
[21] White RH, Glasgow EF, 
Mills RJ. Clinicopathological study 
of nephrotic syndrome in childhood. 
Lancet. 1970;1(7661):1353-1359
[22] Brenner BM, Hostetter TH, 
Humes HD. Glomerular  
permselectivity: Barrier function  
based on discrimination of molecular 
size and charge. The American  
Journal of Physiology. 1978;234(6): 
F455-F460
[23] Kitano Y, Yoshikawa N, 
Nakamura H. Glomerular anionic 
sites in minimal change nephrotic 
syndrome and focal segmental 
glomerulosclerosis. Clinical Nephrology. 
1993;40(4):199-204
[24] Carrie BJ, Salyer WR, Myers BD. 
Minimal change nephropathy: An 
electrochemical disorder of the 
glomerular membrane. The American 
Journal of Medicine. 1981;70(2):262-268
[25] Van den Born J et al. A monoclonal 
antibody against GBM heparin sulfate 
induces an acute selective proteinuria 
in rats. Kidney International. 
1992;41(1):115-123
[26] ISKDC. Nephrotic syndrome in 
children: Prediction of histopathology 
from clinical and laboratory 
characteristics at time of diagnosis. 
Kidney International. 1978;13:159-165
[27] Shih NY et al. Congenital 
nephrotic syndrome in mice lacking 
CD2-associated protein. Science. 
1999;286(5438):312-315
[28] Kaplan JM et al. Mutations in 
ACTN4, encoding alpha-actinin-4, 
cause familial focal segmental 
glomerulosclerosis. Nature Genetics. 
2000;24(3):251-256
[29] Ruf RG et al. Prevalence of WT1 
mutations in a large cohort of patients 
with steroid-resistant and steroid-
sensitive nephrotic syndrome. Kidney 
International. 2004;66(2):564-570
[30] Winn MP et al. A mutation in the 
TRPC6 cation channel causes  
familial focal segmental 
glomerulosclerosis. Science. 
2005;308(5729):1801-1804
[31] Mucha B et al. Members of the APN 
study group. Mutations in the Wilms’ 
tumor 1 gene cause isolated steroid 
resistant nephritic syndrome and occur 
in exons 8 and 9. Pediatric Research. 
2006;59(2):325-331
[32] Boute N et al. NPHS2, encoding the 
glomerular protein podocin, is mutated 
in autosomal recessive steroid-resistant 
nephrotic syndrome. Nature Genetics. 
2000;24:349-354
[33] Barisoni L, Mundel P. Podocyte 
biology and the emerging 
understanding of podocyte diseases. 
American Journal of Nephrology. 
2003;23(5):353-360
13
Causes and Pathophysiology of Nephrotic Syndrome in Childhood
DOI: http://dx.doi.org/10.5772/intechopen.86825
[34] Benzing T. Signaling at the 
slit diaphragm. Journal of the 
American Society of Nephrology. 
2004;15(6):1382-1391
[35] Tryggvason K, Patrakka J, 
Wartiovaara J. Hereditary proteinuria 
syndromes and mechanisms of 
proteinuria. The New England Journal 
of Medicine. 2006;354(13):1387-1401
[36] Barbaux S et al. Donor splice-site 
mutations in WT1 are responsible for 
Frasier syndrome. Nature Genetics. 
1997;17(4):467-470
[37] Morello R, Lee B. Insight into 
podocyte differentiation from the 
study of human genetic disease: Nail-
patella syndrome and transcriptional 
regulation in podocytes. Pediatric 
Research. 2002;51(5):551-558
[38] Boerkoel CF et al. Mutant chromatin 
remodeling protein SMARCAL1 causes 
Schimke immuno-osseous dysplasia. 
Nature Genetics. 2002;30(2):215-220
[39] Zenker M et al. Human laminin 
beta2 deficiency causes congenital 
nephrosis with mesangial sclerosis 
and distinct eye abnormalities. 
Human Molecular Genetics. 
2004;13(21):2625-2632
[40] Shalhoub RJ. Pathogenesis of  
lipoid nephrosis: A disorder of T-cell 
function. Lancet. 1974;2(7880): 
556-560
[41] Kemper MJ, Wolf G, Muller- 
Wiefel DE. Transmission of glomerular 
permeability factor from a mother to 
her child. The New England Journal of 
Medicine. 2001;344(5):386-387
[42] Meyrier A. Mechanisms of disease: 
Focal segmental glomerulosclerosis. 
Nature Clinical Practice Nephrology. 
2005;1(1):44-54
[43] Dantal J et al. Effect of plasma 
protein adsorption on protein excretion 
in kidney-transplant recipients with 
recurrent nephrotic syndrome. The 
New England Journal of Medicine. 
1994;330(1):7-14
[44] Savin VJ et al. Circulating factor 
associated with increased glomerular 
permeability to albumin in recurrent 
focal segmental glomerulosclerosis. 
The New England Journal of Medicine. 
1996;334(14):878-883
[45] Candiano G et al. Inhibition of 
renal permeability towards albumin: A 
new function of apolipoproteins with 
possible pathogenetic relevance in focal 
glomerulosclerosis. Electrophoresis. 
2001;22(9):1819-1825
[46] Topaloglu R et al. T-cell subsets, 
interleukin-2 receptor expression and 
production of interleukin-2 in minimal 
change nephrotic syndrome. Pediatric 
Nephrology. 1994;8(6):649-652
